The optimal management strategy for patent ductus arteriosus in preterm infants remains a
topic of debate. Available evidence for a treatment strategy might be biased by the delayed …

Background Patent ductus arteriosus (PDA) is associated with significant morbidity and
mortality in preterm infants. Several non‐pharmacological, pharmacological, and surgical …

Background Patent ductus arteriosus (PDA) is associated with significant morbidity and
mortality in preterm infants. Cyclooxygenase inhibitors (COX‐I) may prevent PDA‐related …

Background The different management strategies for patent ductus arteriosus (PDA) in
preterm infants are expectant management, surgery, or medical treatment with non‐selective …

Background Germinal matrix hemorrhage and intraventricular hemorrhage (GMH‐IVH) may
contribute to neonatal morbidity and mortality and result in long‐term neurodevelopmental …

Heterogeneity in Treatment Response for Patent Ductus Arteriosus: A Meta-Analysis Page 1
Page 1/21 Heterogeneity in Treatment Response for Patent Ductus Arteriosus: A Meta-Analysis …

neonates. The purpose of this study is to determine the efficacy of prophylactic parenteral
acetaminophen as a safer alternative drug for PDA in preterm infants. Methods: In a …

The Effect of Oral Acetaminophen on Open Arterial Duct Closure in Premature Infants Less
Than 32 Weeks Page 1 54 Original Article Abstract Background: In most term neonates, the …

BackgroundThere is little evidence of the efficacy of acetaminophen prophylaxis in
preventing PDA in premature infants. Regarding the effects of acetaminophen in these …

Objective: To find out the effectiveness of prophylactic parenteral paracetamol to minimize
rates of ductus patency among preterm infants. Study Design: Case-control study. Setting …